PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).
This study is being done to collect cancer-related information from patients with triple negative breast cancer and patients with hereditary genetic mutations. This information will help us better understand the link between genetic changes and cancer outcome in patients with triple negative breast cancer.
Study Type
OBSERVATIONAL
Enrollment
1,500
Hays Medical Center Dreiling-Schmidt Cancer Institute
Hays, Kansas, United States
RECRUITINGKCCC West
Kansas City, Kansas, United States
RECRUITINGPrevalence of germline mutations (such as BRCA1/2 mutations) in patients with TNBC
Time frame: 5 years
. Predictors of response to neo/adjuvant chemotherapy in patients with TNBC
Time frame: 5 years
Long term Disease free and overall survival rates in TNBC patients treated with different systemic therapies
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
KCCC Overland Park
Overland Park, Kansas, United States
RECRUITINGOverland Park Regional Medical Center
Overland Park, Kansas, United States
RECRUITINGSalina Regional Health Center - Tammy Walker Cancer Center
Salina, Kansas, United States
RECRUITINGThe University of Kansas Cancer Center
Westwood, Kansas, United States
RECRUITINGUniverstiy Health
Kansas City, Missouri, United States
RECRUITINGKCCC South
Kansas City, Missouri, United States
RECRUITINGResearch Medical Center
Kansas City, Missouri, United States
RECRUITINGKCCC - North
Kansas City, Missouri, United States
RECRUITING...and 1 more locations